{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:00:19Z","timestamp":1740128419202,"version":"3.37.3"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA025078"],"award-info":[{"award-number":["R01 DA025078"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA184211"],"award-info":[{"award-number":["R01 CA184211"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Individuals with psychiatric conditions smoke at higher rates than the general population and may need more intensive treatment to quit. We examined whether or not extended treatment with nicotine patch, combined with behavior counseling, would disproportionally benefit smokers with versus without a lifetime psychiatric condition.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a secondary analysis of data from an effectiveness trial of treatment with 12 counseling sessions (48 weeks) and 21-mg nicotine patch (8, 24, or 52 weeks) among 525 adult daily smokers. A structured clinical interview assessed past and current psychiatric disorders (major depression, generalized anxiety disorder, alcohol abuse and\/or dependence, and substance abuse and\/or dependence), as described in the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition). Abstinence was bioverified at week 52. Logistic regression evaluated the effect of the psychiatric status \u00d7 treatment duration interaction on abstinence at week 52, covarying for sociodemographics, baseline psychological symptoms, and treatment adherence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>At baseline, 115 (21.9%) participants were diagnosed with one or more psychiatric conditions. The psychiatric status \u00d7 treatment duration interaction was significant for week 52 abstinence (p = .027). Abstinence rates between smokers with versus without a psychiatric condition in the 24-week treatment arm (9.3% vs. 31.5% abstinent) significantly differed from the 8-week treatment arm (18.8% vs. 22.3%), p = .017. Abstinence rates for smokers with (22.5%) versus without a psychiatric condition (19.7%) in the 52-week treatment arm did not differ from those in the 8-week arm.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Targeted smoking cessation treatment, rather than extending treatment duration, may be especially warranted to optimize treatment for smokers with comorbid mood, anxiety, and substance use disorders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Implications<\/jats:title>\n                  <jats:p>Individuals with psychiatric conditions smoke at higher rates and have greater difficulty quitting compared to those in the general population, but little is known about how to best optimize treatment for this high tobacco burden population. The present study found that cessation response to extended duration treatment with the transdermal nicotine patch did not differ for smokers with versus without comorbid anxiety, mood, and substance use disorders in a large-scale clinical effectiveness trial. Development of targeted behavioral treatments may be required to optimize abstinence outcomes for this high-risk population, rather than simply extending the duration of pharmacotherapy treatments.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ntr\/nty191","type":"journal-article","created":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T19:08:54Z","timestamp":1536433734000},"page":"24-31","source":"Crossref","is-referenced-by-count":3,"title":["Extended Nicotine Patch Treatment Among Smokers With and Without Comorbid Psychopathology"],"prefix":"10.1093","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3576-8808","authenticated-orcid":false,"given":"Allison J","family":"Carroll","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3240-5697","authenticated-orcid":false,"given":"Amanda R","family":"Mathew","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank T","family":"Leone","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Presbyterian Medical Center, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E Paul","family":"Wileyto","sequence":"first","affiliation":[{"name":"Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Miele","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A","family":"Schnoll","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Hitsman","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,9,12]]},"reference":[{"volume-title":"Early Release of Selected Estimates Based on Data From the January\u2013September 2015 National Health Interview Survey","year":"2016","author":"Clarke","key":"2020061608132717100_CIT0001"},{"issue":"3","key":"2020061608132717100_CIT0002","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.amepre.2015.01.016","article-title":"Poor mental health and reduced decline in smoking prevalence","volume":"49","author":"Steinberg","year":"2015","journal-title":"Am J Prev Med"},{"issue":"2","key":"2020061608132717100_CIT0003","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jama.2013.284985","article-title":"Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation","volume":"311","author":"Cook","year":"2014","journal-title":"JAMA"},{"issue":"11","key":"2020061608132717100_CIT0004","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/archpsyc.61.11.1107","article-title":"Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"2020061608132717100_CIT0005","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.2105\/AJPH.2013.301502","article-title":"Cigarette smoking and mental illness: a study of nicotine withdrawal","volume":"104","author":"Smith","year":"2014","journal-title":"Am J Public Health"},{"issue":"2","key":"2020061608132717100_CIT0006","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/add.12009","article-title":"Past major depression and smoking cessation outcome: a systematic review and meta-analysis update","volume":"108","author":"Hitsman","year":"2013","journal-title":"Addiction"},{"issue":"12","key":"2020061608132717100_CIT0007","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1080\/14622200802443569","article-title":"Tobacco use and cessation in psychiatric disorders: national institute of mental health report","volume":"10","author":"Ziedonis","year":"2008","journal-title":"Nicotine Tob Res"},{"issue":"e2","key":"2020061608132717100_CIT0008","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1136\/tobaccocontrol-2013-051466","article-title":"Smoking and mental illness in the U.S. population","volume":"23","author":"Smith","year":"2014","journal-title":"Tob Control"},{"volume-title":"Morbidity and Mortality in People With Serious Mental Illness","year":"2006","author":"Parks","key":"2020061608132717100_CIT0009"},{"issue":"8","key":"2020061608132717100_CIT0010","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/ntr\/ntw016","article-title":"Exploring issues of comorbid conditions in people who smoke","volume":"18","author":"Rojewski","year":"2016","journal-title":"Nicotine Tob Res"},{"volume-title":"Treating Tobacco Use and Dependence: 2008 Update","year":"2008","author":"Fiore","key":"2020061608132717100_CIT0011"},{"issue":"8","key":"2020061608132717100_CIT0012","first-page":"CD006102","article-title":"Smoking cessation interventions for smokers with current or past depression","author":"van der Meer","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2020061608132717100_CIT0013","first-page":"CD007253","article-title":"Interventions for smoking cessation and reduction in individuals with schizophrenia","author":"Tsoi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"10037","key":"2020061608132717100_CIT0014","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"2020061608132717100_CIT0015","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/070674370905400604","article-title":"Treatment of tobacco dependence in mental health and addictive disorders","volume":"54","author":"Hitsman","year":"2009","journal-title":"Can J Psychiatry"},{"issue":"4","key":"2020061608132717100_CIT0016","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00023210-200822040-00001","article-title":"Use of smoking cessation therapies in individuals with psychiatric illness: an update for prescribers","volume":"22","author":"Kisely","year":"2008","journal-title":"CNS Drugs"},{"key":"2020061608132717100_CIT0017","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2013.12.010","article-title":"Smoking cessation behaviors among persons with psychiatric diagnoses: results from a population-level state survey","volume":"136","author":"Morris","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"2020061608132717100_CIT0018","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ntr\/ntu239","article-title":"Cessation among state quitline participants with a mental health condition","volume":"17","author":"Kerkvliet","year":"2015","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"2020061608132717100_CIT0019","first-page":"81","article-title":"Prevalence and impact of long-term use of nicotine replacement therapy in UK stop-smoking services: findings from the ELONS study","volume":"20","author":"Shahab","year":"2017","journal-title":"Nicotine Tob Res"},{"issue":"7","key":"2020061608132717100_CIT0020","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/jama.2015.7460","article-title":"Nicotine replacement therapy as a maintenance treatment","volume":"314","author":"Prochaska","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"2020061608132717100_CIT0021","first-page":"349","article-title":"Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia","volume":"1","author":"Dale Horst","year":"2005","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"2020061608132717100_CIT0022","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/jamainternmed.2014.8313","article-title":"Long-term nicotine replacement therapy: a randomized clinical trial","volume":"175","author":"Schnoll","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2020061608132717100_CIT0023","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59(","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"2020061608132717100_CIT0024","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1037\/0893-164X.12.2.101","article-title":"Reliability and validity of a smoking timeline follow-back interview","volume":"12","author":"Brown","year":"1998","journal-title":"Psychol Addict Behav"},{"issue":"3","key":"2020061608132717100_CIT0025","doi-asserted-by":"crossref","first-page":"144","DOI":"10.7326\/0003-4819-152-3-201002020-00005","article-title":"Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial","volume":"152","author":"Schnoll","year":"2010","journal-title":"Ann Intern Med"},{"issue":"6","key":"2020061608132717100_CIT0026","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"2020061608132717100_CIT0027","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0033291700035558","article-title":"The inventory of depressive symptomatology (IDS): psychometric properties","volume":"26","author":"Rush","year":"1996","journal-title":"Psychol Med"},{"issue":"7","key":"2020061608132717100_CIT0028","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1989.tb03059.x","article-title":"Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day","volume":"84","author":"Heatherton","year":"1989","journal-title":"Br J Addict"},{"issue":"1","key":"2020061608132717100_CIT0029","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/jsc.2017.2","article-title":"Factors associated with adherence to transdermal nicotine patches within a smoking cessation effectiveness trial","volume":"13","author":"Handschin","year":"2017","journal-title":"J Smok Cessat"},{"issue":"1","key":"2020061608132717100_CIT0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.pra.0000344917.43780.77","article-title":"Medication adherence: a review of the literature and implications for clinical practice","volume":"15","author":"Julius","year":"2009","journal-title":"J Psychiatr Pract"},{"issue":"10","key":"2020061608132717100_CIT0031","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s11606-011-1704-y","article-title":"Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis","volume":"26","author":"Grenard","year":"2011","journal-title":"J Gen Intern Med"},{"issue":"3","key":"2020061608132717100_CIT0032","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0376-8716(00)00114-9","article-title":"The relationship between psychopathology and smoking cessation treatment response","volume":"60","author":"Gariti","year":"2000","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"2020061608132717100_CIT0033","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jsat.2010.03.007","article-title":"Smoking outcome by psychiatric history after behavioral and varenicline treatment","volume":"38","author":"McClure","year":"2010","journal-title":"J Subst Abuse Treat"},{"issue":"10","key":"2020061608132717100_CIT0034","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.clinthera.2008.09.016","article-title":"Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers","volume":"30","author":"Shiffman","year":"2008","journal-title":"Clin Ther"},{"key":"2020061608132717100_CIT0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/PROM.S11545","article-title":"Nicotine replacement therapies: patient safety and persistence","volume":"2","author":"Ferguson","year":"2011","journal-title":"Patient Relat Outcome Meas"},{"issue":"44","key":"2020061608132717100_CIT0036","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.15585\/mmwr.mm6444a2","article-title":"Current cigarette smoking among adults\u2014United States, 2005\u20132014","volume":"64","author":"Centers for Disease Control and Prevention","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"2020061608132717100_CIT0037","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/ntr\/ntu050","article-title":"Smoking cessation outcomes among sexual and gender minority and nonminority smokers in extended smoking treatments","volume":"16","author":"Grady","year":"2014","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"2020061608132717100_CIT0038","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ntr\/ntw148","article-title":"Is the effect of anhedonia on smoking cessation greater for women versus men","volume":"19","author":"Powers","year":"2017","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"2020061608132717100_CIT0039","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.addbeh.2004.04.005","article-title":"Effects of different nicotine replacement therapies on postcessation psychological responses","volume":"30","author":"Strasser","year":"2005","journal-title":"Addict Behav"},{"issue":"4","key":"2020061608132717100_CIT0040","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1037\/0022-006X.64.4.791","article-title":"Depression and smoking cessation: characteristics of depressed smokers and effects of nicotine replacement","volume":"64","author":"Kinnunen","year":"1996","journal-title":"J Consult Clin Psychol"},{"key":"2020061608132717100_CIT0041","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.drugalcdep.2014.02.007","article-title":"The association between changes in alternative reinforcers and short-term smoking cessation","volume":"138","author":"Goelz","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"2020061608132717100_CIT0042","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12916-016-0626-2","article-title":"Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial","volume":"14","author":"Tulloch","year":"2016","journal-title":"BMC Med"},{"issue":"1","key":"2020061608132717100_CIT0043","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.drugalcdep.2012.12.026","article-title":"Low incidence of adverse events following varenicline initiation among opioid dependent smokers with comorbid psychiatric illness","volume":"132","author":"Nahvi","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"2020061608132717100_CIT0044","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/add.13806","article-title":"Extended treatment for cigarette smoking cessation: a randomized control trial","volume":"112","author":"Laude","year":"2017","journal-title":"Addiction"},{"issue":"12","key":"2020061608132717100_CIT0045","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2105\/AJPH.2010.300084","article-title":"Using extended cognitive behavioral treatment and medication to treat dependent smokers","volume":"101","author":"Hall","year":"2011","journal-title":"Am J Public Health"},{"issue":"8","key":"2020061608132717100_CIT0046","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1525-1497.2004.30423.x","article-title":"Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression","volume":"19","author":"Cox","year":"2004","journal-title":"J Gen Intern Med"},{"issue":"8","key":"2020061608132717100_CIT0047","first-page":"999","article-title":"Combination varenicline\/bupropion treatment benefits highly dependent smokers in an adaptive smoking cessation paradigm","volume":"19","author":"Rose","year":"2017","journal-title":"Nicotine Tob Res"},{"issue":"2","key":"2020061608132717100_CIT0048","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/phar.2073","article-title":"Current and emerging pharmacotherapies for cessation of tobacco smoking","volume":"38","author":"G\u00f3mez-Coronado","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"1","key":"2020061608132717100_CIT0049","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neubiorev.2011.06.007","article-title":"Smoking, quitting, and psychiatric disease: a review","volume":"36","author":"Aubin","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"2020061608132717100_CIT0050","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s10488-010-0324-x","article-title":"A comprehensive model for mental health tobacco recovery in New Jersey","volume":"38","author":"Williams","year":"2011","journal-title":"Adm Policy Ment Health"},{"issue":"3","key":"2020061608132717100_CIT0051","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s13142-012-0111-1","article-title":"Sequential behavioral treatment of smoking and weight control in bipolar disorder","volume":"2","author":"Filia","year":"2012","journal-title":"Transl Behav Med"},{"issue":"10","key":"2020061608132717100_CIT0052","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.2105\/AJPH.2005.080382","article-title":"Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial","volume":"96","author":"Hall","year":"2006","journal-title":"Am J Public Health"}],"container-title":["Nicotine &amp; Tobacco Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ntr\/article-pdf\/22\/1\/24\/33393412\/nty191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ntr\/article-pdf\/22\/1\/24\/33393412\/nty191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T12:20:18Z","timestamp":1592310018000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ntr\/article\/22\/1\/24\/5095857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,12]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,9,12]]},"published-print":{"date-parts":[[2020,1,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ntr\/nty191","relation":{},"ISSN":["1462-2203","1469-994X"],"issn-type":[{"type":"print","value":"1462-2203"},{"type":"electronic","value":"1469-994X"}],"subject":[],"published-other":{"date-parts":[[2020,1]]},"published":{"date-parts":[[2018,9,12]]}}}